News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
04.04.2020 12:08:00

Why Gilead Sciences Is the Hottest Stock to Buy Today

Gilead Sciences (NASDAQ: GILD) is one stock that the coronavirus pandemic hasn't been able to drag down in 2020. While the S&P 500 is down 23% since the beginning of the year, shares of Gilead are up by more than 20% during that time. This resilience is in part because the drug manufacturer may play a key role in helping the world beat the coronavirus. And unlike retailers that depend on many consumers entering their stores, it doesn't have to shut down all or a significant part of its operations to keep people safe.Gilead isn't just a good pick for risk-averse investors who are worried about investing in highly volatile stocks these days -- it looks to be the hottest stock of 2020. Here's why.The biggest reason to be excited about Gilead is the potential that its Ebola drug, Remdesivir, may have in fighting COVID-19. In February, World Health Organization (WHO) Assistant Director-General Bruce Aylward said: "There is only one drug right now that we think may have real efficacy and that's Remdesivir." Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

(Anzeige)Passende emittierte Barrier Reverse Convertibles

Basiswert Valor Fälligkeitstag Maximale Rendite p.a.
Gilead Sciences Inc. / Johnson & Johnson / Pfizer Inc. 39255387 05.08.2020 6.50 %

Analysen zu Gilead Sciences Inc.mehr Analysen

15.03.19 Gilead Sciences Outperform BMO Capital Markets
03.01.19 Gilead Sciences Outperform Oppenheimer & Co. Inc.
26.10.18 Gilead Sciences overweight Barclays Capital
01.10.18 Gilead Sciences Overweight Cantor Fitzgerald
26.07.18 Gilead Sciences Neutral Robert W. Baird & Co. Incorporated

Eintrag hinzufügen

Aktien Top Flop

CS Group 8.85
4.86 %
UBS Group 10.39
3.49 %
Swiss Re 67.98
2.69 %
Swiss Life Hldg 351.40
2.60 %
Adecco Group 46.34
2.52 %
Givaudan 3’396.00
-0.73 %
Lonza Grp 480.20
-1.15 %
Swisscom 488.70
-1.17 %
Roche Hldg G 337.45
-1.98 %
Sika 168.75
-5.12 %
Ruhige Woche bahnt sich an | BX Swiss TV

Aktien in diesem Artikel

Gilead Sciences Inc. 66.00 3.77% Gilead Sciences Inc.

Finanzen.net News